SG184833A1 - Methods of producing high titer, high purity virus stocks and methods of use thereof - Google Patents

Methods of producing high titer, high purity virus stocks and methods of use thereof Download PDF

Info

Publication number
SG184833A1
SG184833A1 SG2012075875A SG2012075875A SG184833A1 SG 184833 A1 SG184833 A1 SG 184833A1 SG 2012075875 A SG2012075875 A SG 2012075875A SG 2012075875 A SG2012075875 A SG 2012075875A SG 184833 A1 SG184833 A1 SG 184833A1
Authority
SG
Singapore
Prior art keywords
virus
tcidso
less
tcids
sample
Prior art date
Application number
SG2012075875A
Other languages
English (en)
Inventor
Damon R Asher
Amanda B Katz
Navid Z Khan
Ushma Mehta
Original Assignee
Emd Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44148425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG184833(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emd Millipore Corp filed Critical Emd Millipore Corp
Publication of SG184833A1 publication Critical patent/SG184833A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14351—Methods of production or purification of viral material

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG2012075875A 2010-04-14 2011-04-08 Methods of producing high titer, high purity virus stocks and methods of use thereof SG184833A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32422010P 2010-04-14 2010-04-14
PCT/US2011/031747 WO2011130119A2 (en) 2010-04-14 2011-04-08 Methods of producing high titer, high purity virus stocks and methods of use thereof

Publications (1)

Publication Number Publication Date
SG184833A1 true SG184833A1 (en) 2012-11-29

Family

ID=44148425

Family Applications (1)

Application Number Title Priority Date Filing Date
SG2012075875A SG184833A1 (en) 2010-04-14 2011-04-08 Methods of producing high titer, high purity virus stocks and methods of use thereof

Country Status (9)

Country Link
US (1) US9644187B2 (cg-RX-API-DMAC7.html)
EP (1) EP2377927B1 (cg-RX-API-DMAC7.html)
JP (3) JP2013523175A (cg-RX-API-DMAC7.html)
KR (1) KR101549296B1 (cg-RX-API-DMAC7.html)
CN (1) CN102985536B (cg-RX-API-DMAC7.html)
BR (1) BR112012026095A2 (cg-RX-API-DMAC7.html)
ES (1) ES2736166T3 (cg-RX-API-DMAC7.html)
SG (1) SG184833A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011130119A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG184833A1 (en) 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
DE102010046817A1 (de) * 2010-09-28 2012-03-29 Sartorius Stedim Biotech Gmbh Verfahren zur Abtrennung von Viren aus einem Kontaminanten enthaltenden flüssigen Medium
US10066213B2 (en) * 2012-03-13 2018-09-04 Emd Millipore Corporation Use of centrifugation-aided infection to increase virus titer
KR101624089B1 (ko) * 2012-11-22 2016-05-24 아사히 가세이 메디컬 가부시키가이샤 고감염가의 파보바이러스의 생산 방법
JP6320429B2 (ja) * 2013-02-22 2018-05-09 エイジェンシー・フォー・サイエンス,テクノロジー・アンド・リサーチ 負帯電粒子を用いるウイルス調製物のクロマトグラフィー精製
US9632087B2 (en) * 2013-09-10 2017-04-25 MockV Solutions Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles
RU2701948C1 (ru) * 2015-11-06 2019-10-02 Асахи Касеи Медикал Ко., Лтд. Способ получения парвовируса, характеризующегося высоким титром инфекционности и высокой чистотой
DE102016005049B4 (de) 2016-04-26 2020-06-18 Sartorius Stedim Biotech Gmbh Verfahren zur Bestimmung des logarithmischen Reduktionswertes LRV eines Größenausschlussfilters
EP3299454A1 (en) * 2016-09-21 2018-03-28 Deutsches Krebsforschungszentrum Optimized method for large scale production of parvovirus h-1 in an essentially serum-free medium
EP3141611A3 (en) * 2016-10-21 2017-05-10 Bayer Healthcare LLC Validation of continuous viral clearance
US10961512B2 (en) * 2017-04-17 2021-03-30 Dao-Yao He Compositions and kits for purification of viral particles from host cells
KR102453351B1 (ko) * 2017-07-05 2022-10-07 에스케이바이오사이언스(주) 인플루엔자 백신용 바이러스 씨드 스톡의 제조 방법
EP3446710A1 (en) * 2017-08-25 2019-02-27 Glenmark Pharmaceuticals S.A. Methods of inactivating viral contaminants
CN108841794B (zh) * 2018-06-08 2021-11-30 苏州良辰生物医药科技有限公司 一种病毒原液的制备方法
JP7588466B2 (ja) * 2020-01-22 2024-11-22 旭化成メディカル株式会社 パルボウイルスの生産方法
EP4112735A4 (en) * 2020-02-28 2023-09-06 Asahi Kasei Medical Co., Ltd. METHOD FOR EVALUATING VIRAL CLEARANCE PERFORMANCE
CN115867807B (zh) * 2020-06-24 2025-10-31 旭化成生命科学股份有限公司 含蛋白质的溶液的评价方法
WO2022060535A1 (en) * 2020-09-21 2022-03-24 Bayer Healthcare Llc Pathogen clearance system and method
US12203914B2 (en) 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
WO2022203044A1 (ja) 2021-03-26 2022-09-29 旭化成メディカル株式会社 ウイルスクリアランス試験の方法
WO2022252098A1 (zh) * 2021-05-31 2022-12-08 中国科学院深圳先进技术研究院 噬菌体制剂的制备方法、药物组合物以及应用
JP7665143B2 (ja) * 2021-06-24 2025-04-21 株式会社島津製作所 ウイルス試料の濃縮方法
WO2026055296A2 (en) * 2024-09-06 2026-03-12 Amgen Inc. Production of viral stocks

Family Cites Families (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3622663A (en) 1968-06-13 1971-11-23 American Home Prod Purification of viruses on treated calcium dihydrogen orthophosphate monohydrate adsorbent
US3919044A (en) 1973-03-28 1975-11-11 Armour Pharma Processes for concentrating and purifying viruses and viral antigens
SU579309A1 (ru) 1973-11-16 1977-11-05 Ленинградский Политехнический Институт Им.М.И.Калинина Способ получени вакцины
FR2475572A1 (fr) 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
JPS6147185A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst 日本脳炎ウイルスの精製方法
JPS6147186A (ja) 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
JPS6147187A (ja) 1984-08-10 1986-03-07 Chemo Sero Therapeut Res Inst 狂犬病ウイルスの精製方法
US6265149B1 (en) 1986-01-22 2001-07-24 Institut Pasteur In vitro diagnostic methods and kits for the detection of HIV-2-specific antibodies
US5824482A (en) 1986-06-23 1998-10-20 Institut Pasteur Purification, cloning, and characterization of a novel human immunodeficiency virus LAVMAL
US4814268A (en) 1986-10-06 1989-03-21 Kreider John W Methods for propagating fastidious human viruses and for producing purified suspensions thereof
US4859597A (en) * 1987-07-27 1989-08-22 Igene Biotechnology, Inc. Production of phage and phage-associated lysin
NZ225583A (en) 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)
US5268292A (en) 1988-06-27 1993-12-07 Robertson Betty H Reproducible generation of high yields of hepatitis A virus by cell culture
GB8914968D0 (en) 1989-06-29 1989-08-23 Connaught Lab Production of virus and purification of viral envelope proteins for vaccine use
US5719051A (en) 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
DE4003543A1 (de) 1990-02-06 1991-08-08 Orpegen Med Molekularbioforsch Verfahren zur abreicherung von viren in loesungen und zur bestimmung der abreicherungsrate von viren
US6709811B1 (en) 1990-05-24 2004-03-23 The United States Of America As Represented By The Department Of Health And Human Services Versatile reagent for detecting murine leukemia viruses
DE69009066T3 (de) 1990-06-15 2001-07-19 Innogenetics N.V., Gent SIV cpz-ant Retrovirus und seine Anwendungen.
IT1248075B (it) 1991-06-18 1995-01-05 Sclavo Spa Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
FR2686097B1 (fr) 1992-01-14 1994-12-30 Rhone Merieux Preparation d'antigenes et de vaccins de virus de la mystery disease, antigenes et vaccins obtenus pour la prevention de cette maladie.
US5658779A (en) 1992-03-20 1997-08-19 Ligochem, Inc. Method of adsorbing viruses from fluid compositions
US5602023A (en) 1992-03-24 1997-02-11 Csatary; Laszlo K. Pharmaceutical product containing live, stabilized virus for the therapy of viral and malignant diseases and process for preparing the same
JP3277045B2 (ja) 1992-10-06 2002-04-22 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング Hiv−グループのレトロウイルスおよびその使用
WO1995025789A1 (en) 1994-03-22 1995-09-28 The Immune Response Corporation Highly efficient production and isolation of viral particles
FR2723740B1 (fr) 1994-08-16 1996-11-08 Pasteur Merieux Serums Vacc Procede de preparation d'antigenes du virus grippal, antigenes obtenus et leurs applications
CA2203809C (en) 1994-10-28 2008-06-03 James M. Wilson Recombinant adenovirus and methods of use thereof
US5756341A (en) 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
US5837520A (en) 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
US6281010B1 (en) 1995-06-05 2001-08-28 The Trustees Of The University Of Pennsylvania Adenovirus gene therapy vehicle and cell line
FR2737730B1 (fr) 1995-08-10 1997-09-05 Pasteur Merieux Serums Vacc Procede de purification de virus par chromatographie
US5840565A (en) 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
JPH11511326A (ja) 1995-08-30 1999-10-05 ジエンザイム コーポレイション アデノウィルスおよびaavの精製
KR100461701B1 (ko) 1996-02-29 2005-04-06 다카라 바이오 가부시키가이샤 바이러스의정제및제거방법
AU2182697A (en) 1996-03-29 1997-10-22 University Of Otago Parapoxvirus vectors
JP2000514290A (ja) 1996-07-01 2000-10-31 ローヌ―プーラン・ロレ・エス・アー 組換えアデノウイルスの製造方法
EP0968284B1 (en) * 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
US7732129B1 (en) 1998-12-01 2010-06-08 Crucell Holland B.V. Method for the production and purification of adenoviral vectors
FR2756297B1 (fr) 1996-11-22 1999-01-08 Centre Nat Rech Scient Procede de production de virus recombinants
US6544769B1 (en) 1996-12-13 2003-04-08 Schering Corporation Compostions comprising viruses and methods for concentrating virus preparations
US6261823B1 (en) 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
ZA982950B (en) 1997-04-08 1998-10-19 Merck & Co Inc Stabilized human papillomavirus formulations
US6995006B2 (en) 1997-09-05 2006-02-07 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
US6410300B1 (en) 1998-01-12 2002-06-25 The University Of North Carolina At Chapel Hill Methods and formulations for mediating adeno-associated virus (AAV) attachment and infection and methods for purifying AAV
US6037456A (en) 1998-03-10 2000-03-14 Biosource Technologies, Inc. Process for isolating and purifying viruses, soluble proteins and peptides from plant sources
US5994134A (en) 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US6146874A (en) 1998-05-27 2000-11-14 University Of Florida Method of preparing recombinant adeno-associated virus compositions
EP1105466B1 (en) 1998-08-14 2006-04-26 Merck & Co., Inc. Process for purifying human papillomavirus virus-like particles
AU5689699A (en) 1998-08-24 2000-03-14 Uab Research Foundation Methods of producing high titer recombinant adeno-associated virus
EP1135468B1 (en) 1998-11-10 2010-01-06 University Of North Carolina At Chapel Hill Virus vectors and methods of making and administering the same
CN1087032C (zh) * 1998-12-14 2002-07-03 彭朝晖 一种生产重组腺病毒的方法
FR2787465A1 (fr) 1998-12-21 2000-06-23 Transgene Sa Procede d'inactivation des virus enveloppes dans une preparation virale de virus non enveloppes
AU779267B2 (en) * 1998-12-31 2005-01-13 Centelion S.A.S. Method for separating viral particles
US6387368B1 (en) 1999-02-08 2002-05-14 The Trustees Of The University Of Pennsylvania Hybrid adenovirus-AAV virus and methods of use thereof
US6793926B1 (en) 1999-05-27 2004-09-21 Genovo, Inc. Methods for production of a recombinant adeno-associated virus
US6316185B1 (en) 1999-09-29 2001-11-13 Mountain View Pharmaceuticals, Inc. Quantitation of viruses by light scattering
US6861001B2 (en) 1999-12-02 2005-03-01 The General Hospital Corporation Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon
JP2003518380A (ja) 1999-12-29 2003-06-10 ジェンザイム・コーポレイション 核酸および他の細胞性汚染混入物質からウイルスベクターを分離するための濾過助剤の使用方法
TWI289158B (en) 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus
US6884613B2 (en) 2000-08-25 2005-04-26 The General Hospital Corporation Selective precipitation of viruses
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
US6825027B2 (en) 2001-12-10 2004-11-30 Baxter Healthcare S.A. Method of production of purified hepatitis a virus particles and vaccine preparation
US7195905B2 (en) 2001-12-10 2007-03-27 Baxter Healthcare S.A. Enveloped virus vaccine and method for production
US6951752B2 (en) 2001-12-10 2005-10-04 Bexter Healthcare S.A. Method for large scale production of virus antigen
CA2469491A1 (en) 2001-12-12 2003-06-19 Kerrie Setiawan Composition for viral preservation
ATE386824T1 (de) 2002-03-29 2008-03-15 Merck & Co Inc Verfahren zur virusproduktion
JP2005521417A (ja) 2002-03-29 2005-07-21 メルク エンド カムパニー インコーポレーテッド アデノウイルスの大規模産生方法及びアデノウイルス種子ストック
DE60327069D1 (de) 2002-04-30 2009-05-20 Oncolytics Biotech Inc Verbesserte reinigungsmethode für viren
EP1506287B1 (en) 2002-05-14 2007-04-25 Merck & Co., Inc. Methods of adenovirus purification
US7419817B2 (en) 2002-05-17 2008-09-02 The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
JP2006507800A (ja) 2002-06-07 2006-03-09 ラージ・スケール・バイオロジー・コーポレイション 可撓性ワクチンアセンブリおよびワクチン送達プラットフォーム
WO2004000220A2 (en) 2002-06-21 2003-12-31 Genetix Pharmaceuticals, Inc. Methods for purifying viral particles for gene therapy
WO2004007537A2 (en) * 2002-07-10 2004-01-22 Transgene S.A. Modified adenoviral fiber with ablated to cellular receptors
AU2003264144C1 (en) 2002-09-05 2009-12-17 Bavarian Nordic A/S Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
US20050009168A1 (en) 2003-05-12 2005-01-13 Robbins Joan Marie Methods and apparatus for Adeno associated virus purification
CA2529053A1 (en) 2003-06-18 2004-12-29 Onyx Pharmaceuticals, Inc. Method for purifying virus
AU2003272868A1 (en) 2003-10-15 2005-04-27 Agtc Gene Technology Company Ltd. Method for large-scale production, isolation, purification and the uses of multi-type recombinant adeno-associated virus vectors
CA2551026A1 (en) * 2003-12-23 2005-07-14 Schering Corporation Methods for producing a549 cell lines stable in serum-free medium suspension culture
CN1922308A (zh) 2004-02-23 2007-02-28 克鲁塞尔荷兰公司 病毒纯化方法
AU2005245943A1 (en) 2004-05-20 2005-12-01 Id Biomedical Corporation Process for the production of an influenza vaccine
ES2932278T3 (es) 2004-06-01 2023-01-17 Genzyme Corp Composiciones y métodos para prevenir la agregación del vector AAV
DE102004049290A1 (de) 2004-10-09 2006-04-20 Bayer Healthcare Ag Verfahren zur Herstellung von Virusmaterial
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
CN101080488A (zh) 2004-11-03 2007-11-28 因特罗根治疗公司 生产和纯化腺病毒载体的新方法
US20060281075A1 (en) 2004-12-22 2006-12-14 Large Scale Biology Corporation Purification of viruses, proteins and nucleic acids
US7344839B2 (en) 2004-12-23 2008-03-18 Aurx, Inc. Virus preparations and methods
ATE412737T1 (de) 2005-04-11 2008-11-15 Crucell Holland Bv Virusreinigung mit ultrafiltration
DE102005047301B4 (de) 2005-09-30 2009-04-16 Sartorius Stedim Biotech Gmbh Verfahren zum Nachweis der Virenabreicherung für die Validierung von Filtern und Filtrationsprozessen
WO2007059473A2 (en) 2005-11-12 2007-05-24 Introgen Therapeutics, Inc. Methods for the production and purification of adenoviral vectors
US7754421B2 (en) 2005-11-18 2010-07-13 National Research Council Of Canada Detection of intact recombinant viruses
KR101157176B1 (ko) 2005-12-20 2012-06-20 삼성전자주식회사 세포 또는 바이러스의 농축 또는 정제용 미세유동장치 및방법
CN101528916B (zh) * 2006-04-28 2013-09-04 宾夕法尼亚大学托管会 规模可调的aav生产方法
US7851196B2 (en) 2006-05-01 2010-12-14 The Regents Of The University Of California Methods for purifying adeno-associated virus particles
BRPI0716145B1 (pt) * 2006-09-01 2021-06-22 Bharat Biotech International Limited Composição de vacina e método para preparar uma composição de vacina para o vírus chikungunya
JP2010512748A (ja) 2006-12-15 2010-04-30 シェーリング−プラウ・リミテッド インフルエンザウイルスを培養物中で複製するための方法
US20080299545A1 (en) * 2007-03-06 2008-12-04 Shuyuan Zhang Chromatographic methods for assessing adenovirus purity
CA2683977C (en) * 2007-03-14 2017-04-25 Ligocyte Pharmaceuticals, Inc. A method of norovirus virus-like particle purification comprising ion exchange chromatography
US8138289B2 (en) 2007-03-27 2012-03-20 University Of Maryland, College Park Imprinted polymeric materials for binding various targets such as viruses
BRPI0811499B8 (pt) 2007-05-04 2021-05-25 Baxalta GmbH métodos para purificar um vírus ou antígeno viral, e para preparar uma vacina contra um vírus ou antígeno viral.
AU2009214768B2 (en) * 2008-02-12 2015-01-22 Sanofi Pasteur Limited Methods using ion exchange and gel filtration chromatography for poxvirus purification
SG184833A1 (en) 2010-04-14 2012-11-29 Emd Millipore Corp Methods of producing high titer, high purity virus stocks and methods of use thereof
US9651469B1 (en) * 2016-01-27 2017-05-16 General Electric Company Electrostatic particle sensor

Also Published As

Publication number Publication date
WO2011130119A3 (en) 2012-03-29
EP2377927B1 (en) 2019-05-22
US9644187B2 (en) 2017-05-09
JP6284500B2 (ja) 2018-02-28
ES2736166T3 (es) 2019-12-26
KR20130020954A (ko) 2013-03-04
WO2011130119A2 (en) 2011-10-20
EP2377927A1 (en) 2011-10-19
JP2017195897A (ja) 2017-11-02
WO2011130119A8 (en) 2011-12-29
JP6522054B2 (ja) 2019-05-29
US20120088228A1 (en) 2012-04-12
CN102985536B (zh) 2017-12-05
JP2015126757A (ja) 2015-07-09
BR112012026095A2 (pt) 2015-09-15
CN102985536A (zh) 2013-03-20
KR101549296B1 (ko) 2015-09-01
JP2013523175A (ja) 2013-06-17

Similar Documents

Publication Publication Date Title
US9644187B2 (en) Methods of producing high titer, high purity virus stocks and methods of use thereof
JP6496684B2 (ja) 組換えaavベクターの改良された精製方法
CN106574252B (zh) 从细胞培养物中纯化脊髓灰质炎病毒的方法
US12305198B2 (en) Virus purification and formulation process
Lothert et al. Membrane-based steric exclusion chromatography for the purification of a recombinant baculovirus and its application for cell therapy
Loewe et al. Opportunities to debottleneck the downstream processing of the oncolytic measles virus
US10336988B2 (en) Methods for purification of a virus produced in vitro and clearance assay for the virus
EP2825639B1 (en) Use of centrifugation-aided infection to increase virus titer
Luong et al. Rapid bench to bedside therapeutic bacteriophage production
JP7390466B2 (ja) ウイルスクリアランス性能の評価方法
JP2019519213A (ja) ポリジアリルジアルキルアンモニウム塩を使用したアデノ随伴ウイルスを単離する方法
JP7588466B2 (ja) パルボウイルスの生産方法
Shoaebargh et al. Developing and Optimizing Monolithic Column Chromatography Purification Process for Oncolytic Rhabdoviral Vectors
CN120843734A (zh) 病毒清除性能的确定方法
Soni VIRAL SAFETY EVALUATION OF BIOTECHNOLOGY PRODUCTS: DEVELOPMENT AND OPTIMIZATIONOF RELIABLE VIRAL CLEARANCE STRATEGIES
Poelsler et al. Validation of adventitious agent safety in Yimmugo®, a novel IVIG preparation for human use
Shoaebargh Addressing the Downstream Processing Challenges Within Manufacturing of Oncolytic Rhabdoviruses
KR20210133732A (ko) 인플루엔자 바이러스 항원 정제 조건 신속 확인 시험
Salm Ligands from combinatorial peptide libraries for virus removal
HK40000235B (en) Methods for isolating adeno-associated virus using a polydiallyldialkylammonium salt